pecially in older adults who accumulate the most sedentary volumes and have the highest risk of comorbidities. 2, 3 Furthermore, accumulating sedentary time in prolonged bouts (eg, binge television watching) exacerbates these deleterious effects. 4 Although behavioral interventions can increase moderate-intensity activity, the transfer to sedentary behaviors remains unclear.
Methods | Institutional review boards at all sites approved the study protocol. Written informed consent was obtained from all participants. This study was a post hoc exploratory analysis of the Lifestyle Interventions and Independence for Elders (LIFE) study, a blinded randomized clinical trial conducted in 8 US centers between February 2010 and December 2013 (protocol for exploratory analysis is available in the Supplement). A moderate-intensity physical activity intervention (PA group) with a goal of 150 minutes per week of walking, in addition to strength, flexibility, and balance training, compared with a health education program (HE group) focused on elderly health, reduced the risk of major mobility disability in adults aged 70 to 89 years with mobility impairments. 5 The PA group primarily focused on increasing overall activity levels; it did not specifically target reducing sedentary behaviors such as television viewing. Participants were instructed to wear an accelerometer on the hip for 7 consecutive days during waking hours at baseline and 6, 12, and 24 months after randomization. 6 Supplemental content Total sedentary time was defined as minutes registering fewer than 100 activity counts per minute per waking day. Total sedentary time was divided into bout lengths of 10 minutes or more, 30 minutes or more, and 60 minutes or more-each overlapping bout length represents a consecutively smaller segment of total sedentary time because longer bouts are less frequently observed. Mean differences in sedentary outcomes were estimated using linear mixedeffects modeling using the intention-to-treat approach in which participants were grouped according to randomization assignment. An α of .05 and 2-tailed alternative hypothesis testing was used for models adjusted for baseline sedentary value, age, sex, clinical site, and accelerometer wear time. Missing values were treated as missing completely at random. Accelerometer data were processed using R (R Foundation), version 3.4.0, and statistical analyses were performed using STATA (StataCorp), version 13.
Results | Of the 1635 participants, 1341 had valid accelerometer data at baseline (≥10 hours/d for ≥3 days), 669 in the PA group and 672 in the HE group. Over 24 months, 1271 had at least 1 follow-up assessment and 1164 participants had data collected at the 24-month visit. Mean age was 79 years, 67% were women, 76% were non-Hispanic white, mean body mass index (calculated as weight in kilograms divided by height in meters squared) was 30, and 42% had a walking speed less than 0.8 m/s. At baseline, participants wore the accelerometer for a mean of 870 minutes per day, spending 647 minutes per day in total daily sedentary time (Figure) . At 6 months, the PA group accrued 630 total sedentary minutes per day and the HE group accrued 639 total sedentary minutes per day (group difference, −9 minutes [95% CI, −14 to −3]; P = .002). This difference persisted over the following 18 months (intervention × time interaction P = .61), although both groups became increasingly sedentary.
At baseline, participants spent a mean of 488 minutes per day in sedentary bouts of 10 minutes or more; 296 minutes per day in sedentary bouts of 30 minutes or more, and 145 minutes per day in sedentary bouts of 60 minutes or more ( Figure) . At 6 months, the PA group accumulated less sedentary time than the HE group in bouts of 10 minutes or more (475 minutes in the PA group vs 487 minutes in the HE group; group difference, −12 minutes [95% CI, −19 to −4]; P = .003) and bouts of 30 minutes or more (290 minutes in the PA group vs 299 minutes in the HE group; group difference, −9 minutes [95% CI, −17 to −1]; P = .02). Intervention differences were maintained over 24 months (intervention × time interaction P > .37 for both). No intervention differences were detected for bouts of 60 minutes or more. Both groups became increasingly sedentary across all bouts.
Discussion | In older adults with mobility impairments, longterm, moderate-intensity physical activity was associated with a small reduction in total sedentary time, reflected in shorter bout lengths. Limitations include the inability to detect posture, napping, behavior types (eg, television watching), and whether changes in sedentary time were clinically meaningful. Overall, traditional approaches to increasing moderateintensity physical activity have little transfer to reductions in total sedentary time and no transfer to prolonged bouts lasting an hour or longer. Additional behavioral approaches are needed to target and reduce sedentary behaviors. 
COMMENT & RESPONSE

Vitamin D Supplementation and Cancer Risk
To the Editor Dr Lappe and colleagues concluded that vitamin D and calcium supplementation compared with placebo did not reduce the risk of cancer in healthy older women.
1 However, we believe their conclusion may be premature. First, the 4-year length of follow-up may have been insufficient. Keum and Giovannucci 2 reported that over 2 to 7
years the benefit of vitamin D supplementation may be limited to cancer mortality without much of an effect on cancer incidence. Second, the higher rate of use of estrogenic agonists and antagonists in the placebo group could have affected cancer risk.
Third, in their post hoc analysis, serum 25-hydroxyvitamin D (25[OH]D) level was inversely and significantly correlated with cancer incidence. The post hoc Kaplan-Meier analysis also supported a significant role for vitamin D.
Fourth, the participants had a mean 25(OH)D level above the mean of the US population. Had the trial been conducted on a study population with lower mean 25(OH)D levels, there might have been a greater chance of finding a significant beneficial effect.
Fifth, in the Supplement, the hazard ratio for cancer continued to decline with increasing 25(OH)D values up to 60 ng/mL before some flattening in the curves was detected.
Even with these limitations, the study almost achieved statistical significance (P = .06) and the findings may still be clinically significant. In Reply Ms Jaroudi and Dr Peiris suggest that the length of follow-up in our study may have been insufficient to detect a change in cancer incidence. We agree that longer follow-up would have been desirable, but we were limited by funding. However, mechanisms proposed for potential anticancer effects include signaling that may result in short-term effects. 1, 2 They are also concerned that the higher use of estrogen agonist and antagonist use in the placebo group may have affected the results. However, an analysis adjusting for use had a hazard ratio of 0.70 (95% CI, 0.47 to 1.02), which did not quite meet statistical significance.
Our post hoc Kaplan-Meier analysis did find a significant inverse association between achieved concentration of 25(OH)D and cancer incidence (P = .03). Our previous study and studies of others reported similar findings. 3, 4 As Jaroudi and Peiris note, the study cohort had higher baseline 25(OH)D levels compared with the US population. This may have biased our study toward the null. We found that vitamin D decreased cancer incidence even in the group with high baseline 25(OH)D levels.
The writers observe that the hazard ratio for cancer continued to decline with increasing serum 25(OH)D values up to 60 ng/mL without substantial flattening. This suggests that future studies should target a higher serum 25(OH)D level than the present study achieved, ideally in the range of 60 ng/mL.
In the vitamin D group, 3.89% developed a new cancer compared with 5.58% in the placebo group; the difference between groups and the Kaplan-Meier incidence over 4 years both had P values of .06 and thus did not quite reach statistical significance. The hazard ratio was 0.70 (95% CI, 0.47 to 1.02).
P values very close to the threshold of .05 are considered to be marginal and should be carefully interpreted. 5 Given that a previous randomized clinical trial found a statistically significant decrease in incidence of cancer of all types combined with vitamin D 3 and calcium compared with placebo, 3 that the current trial may have been underpowered, and that post hoc analyses were suggestive, the possibility that the results were clinically significant should be considered. The 30% reduction in the hazard ratio suggests that this difference may be clinically important.
Title: Effects of a chronic physical activity program on accelerometry-based sedentary time in older adults participating in the LIFE study.
Research questions:
Question 1: Compared to a health education program, how does a 2-year structured physical activity program modify total sedentary time and bouts of sedentary time in mobility limited older adults?
Hypothesis: Older adults randomized to the physical activity program will experience a decrease in sedentary time and will spend shorter bouts being sedentary when compared to counterparts engaged in a health education program.
Question 2: Is the change in sedentary time (either total time or bout changes) associated with change in physical function in mobility limited older adults?
Hypothesis: Increases in both total sedentary time and bouts of sedentary time will be associated with declining physical function in older adults enrolled in the LIFE study.
Brief introduction:
Rising levels of sedentary activity among older Americans have emerged as a national public health concern 1 . This type of sitting-like activity has been linked to many adverse health outcomes including diabetes, cardiovascular disease and metabolic syndrome [2] [3] [4] . Coupled with aging effects, increased risk of these comorbidities can affect independence later in life 5, 6 . Though physical activity has been shown to combat these risks 7 , extant literature suggests that the effects of sedentary activity are independent of engaging in a structured physical activity program 8, 9 . However, when older adults are introduced to a physical activity regiment, it is not clear whether sedentary activity is changed in the process. This reveals a gap in the knowledge to the magnitude and directionality among changes in sedentary activity when individuals engage in a structured physical activity intervention. To address this gap, this study first aims to longitudinally assess how objectively measured sedentary activity changes with a structured physical activity intervention compared with a health education program. Second, we will examine whether there is a shift in how sedentary time is accumulated following randomization to a physical activity or health education program among older adults participating in the LIFE study.
Outcomes to be used or calculated from raw accelerometry data:
• Daily sedentary time (assessed with accelerometry at baseline, 6 mo, 12 mo, and 24 mo)
• A bout of sedentary behavior will be defined as consecutive minutes in which the accelerometer registered less than 100 counts per minute. Sedentary bouts will be calculated two ways. o Number of bouts , and 30 min o Time accumulated with each bout category • The bout data will also be summarized into a single measure to describe the data. We will determine the bout length where 50% of the total sedentary time is accumulated (i.e., the minimum X such that 50% of the total sedentary time is accumulated in bouts <= X minutes)
• SPPB score and 400 meter walk speed • Change scores will be calculated by subtracting the last follow-up value from the baseline value (FU-Baseline value)
Pre-processing and data reduction of sedentary bouts: This analysis requires pre-processing of the raw accelerometry data. We will obtain the raw data from DMAQC and implement the methodology outlined by Shiroma and colleagues 10 . UF investigators have specific expertise processing raw accelerometry data using custom code developed in MatLab. The code to derive these results and the resultant summary bout data will be provided to DMAQC for their review and input.
Distribution of the sedentary bout data:
The distribution of the sedentary bout data will be evaluated prior to conducting analyses. In short, the number of bouts >1 min has a large range and is likely to be normally distributed. The number of bouts >10 and >30 are obviously truncated, but there remains sufficient variability. We will visualize the data and perform standard diagnostic tests to evaluate normality prior to running a specific parametric model. If normality is not retained then we will perform appropriate transformation. If that is not sufficient, then we will categorize the data into quantiles and perform a non-linear mixed model technique that are readily available in most statistics packages (e.g. nlmixed in STATA). The analyses proposed below assume that the data are normally distributed.
Primary analysis approach:
Sedentary time is defined as the amount of time in movement which is <100 cts/min captured through accelerometry. Daily sedentary time is available in baseline and follow-up datasets. Sedentary bouts are defined as spending pre-defined time intervals
, and 30 min in activity that is <100 cts/min.
Because there are concerns about balance between randomized groups due to missing baseline accelerometry data, Table 1 will report participant characteristics according to intervention and comparison groups. Descriptive statistics (t-test, chi squared, Wilcoxon, etc…) will be examined across treatment groups. Tables 2 and 3 will report the average sedentary time at baseline and follow up visits (6, 12 , and 24 months) by intervention groups. Mean differences in sedentary time and bouts between intervention groups will be estimated using mixed effects (random and fixed) linear modeling, with the baseline value, follow-up visit (random effect), and an intervention by visit interaction included in the model. Factors used to stratify randomization (site and gender) will be included in the model. The follow-up visit will be considered the random effect in this model.
The association between the change in sedentary time and change in physical function will also be examined. For this analysis, the intervention groups will be collapsed to increase variability to detect associations and a simple linear regression analysis will be fitted against change scores. Both change in SPPB score and 400 meter walk speed will be examined. Partial R-square values will be reported as seen in Table 4 . Prior to performing this analysis, we will visually examine potential non-linearity in the relationship between sedentary time and physical function (e.g. quadratic) and perform appropriate analysis to capture this if it exists. We will also explore the effect of the interventions on this relationship. We will either adjust for intervention group or the total number of counts accumulated above 100 ct/min as a proxy of physical activity. We will explore these approaches in sensitivity analyses.
Missing data and Supplementary analyses:
There are missing accelerometry data at baseline. Approximately 300 people do not have valid accelerometry data at baseline. Therefore, only participants that have valid data at baseline will be included in this analysis (n ~ 1300). We can assume this data is missing at random, but there is a concern that it might not be random and there will be group differences at baseline. We will first examine differences in characteristics between participants with and without complete accelerometry data at baseline. If differences exist between the interventions groups as a result of missing data then we will explore adjusting for covariates (e.g. demographics, BMI etc…) to help equalize the groups.
We also expect to have missing data at follow-up visits. We will conduct supplementary analyses to examine potential differences in the results when only including participants with complete data (data on all measures) versus including participants with one or more missing values. Differences between the complete and non-complete data will result in discussions with DMAQC on appropriate modifications to the analysis.
We will perform supplementary analyses on participants to examine a potential modifying effect of having a low SPPB at baseline (low is defined as < 8). We will examine modification by including an intervention group by SPPB group interaction term in the model. A significant interaction (P<0.1) will result in stratified analyses. 
Anticipated tables:
